• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Mike Doustdar Novo Nordisk Novo Novo CEO
Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner Jun 11, 2026 7:00am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Novo’s Wegovy keeps gaining ground

Jun 12, 2026 2:30pm
Tavneos

Amgen to file 3rd-party review of Tavneos data for FDA hearing

Jun 12, 2026 11:12am
Jazz

Zepzelca saga takes another turn with ph. 3 lung cancer flop

Jun 12, 2026 10:48am
Food and Drug Administration

Regulatory tracker: Novo's oral GLP-1 picks up UK approval

Jun 12, 2026 9:50am
Asia

Astellas, Takeda, RA Capital—Fierce Pharma Asia

Jun 12, 2026 8:23am
More News

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
Fierce Biotech

3 Genentech VPs among those dismissed in latest layoff round

Jun 11, 2026 2:30pm
Fierce Healthcare

HHS ramps up AI use cases, with most in pre-deployment: BPC

Jun 11, 2026 2:00pm

Novo reports data breach, urges patients to 'remain vigilant'

Jun 11, 2026 1:18pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings